Childhood Medulloblastoma Cancer

What is Medulloblastoma Cancer?

Medulloblastoma cancer is an aggressive brain tumor that originates in the brain’s cerebellum — an area that regulates a person’s balance and sense of equilibrium. According to the National Library of Medicine, “Medulloblastoma is the most common malignant brain tumor in children, constituting nearly 20% of all pediatric brain tumors.”1  While this type of tumor can occur in adults, it typically affects more children — with approximately 350-500 diagnosed each year in the United States.2 

Medulloblastoma Cancer Symptoms, Causes, and Risk Factors

Medulloblastoma cancer symptoms can present gradually or abruptly depending on how advanced the tumor growth is. In some cases, the tumor may spread to the patient’s spinal cord via cerebral spinal fluid (CSF), affecting the central nervous system. 

In cases where the tumor blocks the flow of CSF, it can result in hydrocephalus, an over-accumulation of CSF in the ventricles of the brain (parts of the brain where CSF flows). This fluid build-up causes intracranial pressure. Signs of a brain tumor can include:

   • Headaches 
   • Seizures 
   • Changes in balance
   • Tripping (due to a change in gait)
   • Frequent falling
   • Issues with vision
   • Lethargy
   • Vomiting
   • Nausea
   • Incontinence 
   • Cognitive changes 
   • Behavior changes

Medulloblastoma pediatric brain tumors are considered embryonal neuroepithelial, meaning they grow from a patient’s cells when they are in utero. Typically, these cells are not harmful, but they can become malignant in a handful of cases. 

The exact cause of this pediatric brain cancer is unknown, but research suggests that genetic factors may play a role. Cedars Sinai reports that “A small number of people with medulloblastoma also have certain inherited disorders. These disorders increase their risk of getting these tumors, as well as other types of cancer.”3 The disorders include:

   • Gorlin syndrome
   •
 Turcot syndrome
   •
 Gardner syndrome
   •
 Li-Fraumeni syndrome

Diagnosis of Medulloblastoma Childhood Cancer

If someone is experiencing any of the signs of pediatric brain tumors mentioned above, it’s important to see a doctor for further evaluation. This type of pediatric brain tumor is typically diagnosed through: 

   • Magnetic resonance imaging (MRI) 
   •
 Computed tomography scan (CT scan)

These methods are non-invasive and allow doctors to collect detailed images of the brain and spinal cord to determine a course of treatment. 

 

Pediatric Cancer Medulloblastoma Treatment & Prognosis

Doctors typically perform surgery to remove as much of the pediatric brain tumor as possible. Once the surgery is complete, the tumor will be examined to determine its pathology. There are three subgroups of medulloblastoma cancer that ultimately determine the specific course of treatment. 

The subgroups are as defined in a study published by the American Society for Clinical Oncology called “WNT-Activated Medulloblastomas With Hybrid Molecular Subtypes”4 quoted below: 

Wingless Type (WNT) Subgroup

   • Long-term prognosis: Good (in fact, the best out of all the subgroups) 
   •
 “Defined by activating mutations in the WNT/β-catenin signaling pathway (eg, CTNNB1 or germline APC), and are often associated with loss of chromosome 6.”

 

Sonic Hedgehog (SHH) Subgroup

   • Long-term prognosis: Greater rates of survival are recorded in infants and depending on the age of diagnosis, the prognosis worsens. 
   •
 “Denoted by mutations in the Sonic Hedgehog (SHH) pathway, with intermediate or poor prognosis guided by TP53 status.”

 

Groups 3 & 4 (Combined Non-WNT/Non-SHH)

   • Long-term prognosis: Group 3 typically has a poor prognosis, while Group 4 has a similar prognosis to the SHH subgroup.
   •
 “G3 and G4 medulloblastomas are associated with MYC amplification and MYCN or CDK6 amplification, and frequently harbor isochromosome 17q.”
   •
 The World Health Organization (WHO) combined Groups 3 and 4 into one subgroup in 2016, “Due to common genetic abnormalities,” as outlined in a study published by Anticancer Research.5

A woman is standing in front of an x-ray machine

SOURCE: Penn Medicine News

In addition to surgical intervention, patients usually undergo chemotherapy and radiation. Doctors may also target the spinal cord or other affected areas with radiation depending on metastasis. While radiation is part of the standard treatment protocol for this type of pediatric brain tumor, the acute toxicity of treatment to the brain, in particular, can cause lasting damage. 

One of the newer and safer treatments for medulloblastoma cancer in children is proton therapy. Pediatric cancer medulloblastoma patients who received proton therapy had better long-term survival rates than those who underwent traditional chemotherapy and radiation. Proton beam therapy allows for the safe delivery of positively charged protons to the tumor site with minimal radiation side effects and damage to surrounding tissue.6

Each medulloblastoma childhood cancer prognosis varies from case to case. However, if treated early and aggressively, and the tumor has not spread to other areas, about 70% of [patients] diagnosed with medulloblastoma are still alive five years later.7 

Solving Kids’ Cancer’s Role in Brain Cancer Awareness & Research 

Brain cancer is the leading cause of cancer death among pediatric patients. Despite significant improvements in outcomes for some rare pediatric cancers, when current treatments such as chemotherapy, surgery, or radiation fail, there is still an unacceptably low chance of survival for some brain cancers. This is mainly due to more aggressive pediatric brain tumors and insufficient research and funding. 

Continued clinical research of medulloblastoma helps scientists study the behavior and biology of this pediatric brain tumor and examine the efficacy of new drugs, those traditionally used for other diseases, and rational combinations. More recent studies include:

  • An examination of medulloblastoma’s diverse biological subtypes to improve risk prediction and personalize treatment strategies.8 
  • Discoveries of the environment around the tumor that is leading to better-targeted treatments for medulloblastoma.9

By investing in innovative, new experimental treatments for children, Solving Kids’ Cancer is dedicated to improving long-term survivorship and increasing brain cancer awareness. 

When you make a gift to Solving Kids’ Cancer, you provide hope to children and their families searching for a cure for rare brain cancers like medulloblastoma cancer — because every kid deserves to grow up®.

A pink button that says `` help fund our research '' on a white background.
Sources
1 Medulloblastoma – https://www.ncbi.nlm.nih.gov/books/NBK431069/
2 An oncolytic measles virus–sensitive Group 3 medulloblastoma model in immune-competent mice – https://academic.oup.com/neuro-oncology/article/20/12/1606/5038008
3 Medulloblastoma – https://www.cedars-sinai.org/health-library/diseases-and-conditions/m/medulloblastoma.html
4 WNT-Activated Medulloblastomas With Hybrid Molecular Subtypes – https://ascopubs.org/doi/full/10.1200/PO.19.00332
5 Molecular Stratification of Medulloblastoma: Clinical Outcomes and Therapeutic Interventions – https://ar.iiarjournals.org/content/42/5/2225.long#sec-4
6 Two Studies Show Promise, Safety of Proton Therapy in the Brain in Children with Cancer – https://www.pennmedicine.org/news/news-releases/2019/september/two-studies-show-promise-safety-of-proton-therapy-in-the-brain-in-children-with-cancer
7 Medulloblastoma – https://my.clevelandclinic.org/health/diseases/22591-medulloblastoma
8 Medulloblastoma: Current Perspectives and Recent Advances – https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911713/
9 Epigenetics and immune cells in medulloblastoma – https://pubmed.ncbi.nlm.nih.gov/36968588/
A man and a little girl are sitting in front of a wooden wall.
By duda November 20, 2024
Ahana’s Story of Strength with High-Risk Neuroblastoma Every day, over 1,000 children worldwide are diagnosed with cancer,1 and for many families, that diagnosis means facing an uncertain future. At just 20 months old, Ahana was diagnosed with a rare and aggressive cancer that had already spread through her small body. Her family’s search for life-saving childhood cancer treatments led them from South Africa to Spain and possibly toward a clinical trial in New York. Ahana’s journey shows the importance of supporting organizations like Solving Kids’ Cancer, which works to find, fund, and advocate for advanced treatments that give hope to families fighting against tough-to-treat rare pediatric cancers.
A poster for 2024 year in review for solving kids ' cancer
November 11, 2024
Advancing Childhood Cancer Research: SKC’s 2024 Milestones
A group of children are holding a sign that says `` lace up for kids 2024 ''.
October 1, 2024
Lace Up for Kids: Your Impact on Childhood Cancer Research At Solving Kids’ Cancer, our mission has always been driven by hope — hope for better treatments, hope for breakthroughs, and most importantly, hope for every child fighting cancer. This year’s Lace Up for Kids campaign was nothing short of inspiring. Together, we’ve raised over $264,000 across the entire campaign, funding innovative childhood cancer research and providing more treatment options for children in need.  From coast to coast, nearly 4,000 participants have stepped up to lace up their gold shoelaces and make a difference. Whether it was through schools, sports teams, or community groups, the show of support has been overwhelming throughout the years. Over 7,823 donations have been made to accelerate new treatments, and the hashtag #CareWearShare has been used 13,864 times, spreading the message far and wide!
A girl is standing in front of a car in a parking lot.
September 2, 2024
Gold Laces for Childhood Cancer Awareness Month: Erin’s Story 
A group of children are standing in a circle with their shoes on the floor.
August 8, 2024
Smithtown Goes Gold for Childhood Cancer Awareness Month!
A poster for lace up for kids with a butterfly on it
August 6, 2024
Childhood Cancer Awareness Month: Lace Up for Kids 2024
A man standing on top of a mountain with the words osteosarcoma survivor to surgeon dr. kurt weiss ' story
August 1, 2024
Osteosarcoma Survivor to Surgeon: Dr. Kurt Weiss’ Story
Jacob 's journey : a childhood cancer survivor 's story
May 10, 2024
Jacob’s Journey: A Childhood Cancer Survivor’s Story Every battle has its heroes, and among the bravest are young children like Jacob Mozer, who faced stage 4 high-risk neuroblastoma when he was barely old enough to walk. Diagnosed at only 16 months old, Jacob’s early years were filled with constant medical appointments and intense treatments. Despite these challenges, today, Jacob is a shining example of the remarkable progress in pediatric oncology. He’s not merely surviving; he’s thriving as a pharmacy resident, driven to give back to the medical community that gave him a second chance at life. During National Cancer Survivors Month this June, we honor and celebrate fighters like Jacob who have battled cancer and emerged stronger. This month also serves to amplify the conversation about pediatric cancer survivorship and push for vital research that continues to save lives. Solving Kids’ Cancer (SKC) plays an essential role in this effort, supporting children like Jacob by funding crucial clinical trials that enhance survival rates and improve the quality of life for those fighting fatal childhood cancers.
A close up of a person holding a test tube in a laboratory.
May 2, 2024
Trailblazing Treatments for Pediatric Brain Tumors Picture a fortress built to guard precious treasure but accidentally also keeps out the very allies it needs in a time of crisis. This is the challenge faced by medical researchers when dealing with the brain’s natural defense — the blood-brain barrier — especially in children with brain tumors. At Columbia University Medical Center, Dr. Luca Szalontay is leading the charge to breach this fortress with groundbreaking approaches. Recently, Dr. Timothy Cripe from Solving Kids’ Cancer’s podcast, This Week in Pediatric Oncology (TWIPO) , interviewed Dr. Szalontay to delve deeper into these innovative treatments. This Brain Tumor Awareness Month, we’re shining a light on these important advances in treating children’s cancer. Understanding the Challenge Treating pediatric brain tumors like diffuse midline glioma (DMG) is especially tough because of the brain’s own protective shield, known as the blood-brain barrier. This barrier keeps out most chemotherapy drugs as well as large molecules, like antibodies, making it hard to treat the tumors effectively. Dr. Szalontay describes the dilemma: “Our field hasn’t been able to advance as quickly as it has with leukemias or other solid tumors because the drugs don’t penetrate the brain efficiently.” She adds on the nature of this blood-brain barrier, “It’s evolutionary, very important to protect us from different toxins and harmful agents, but this is a shield which protects the tumor as well.” Even when drugs work well in lab tests, they struggle to get to the tumor in strong enough doses without harming the body. Dr. Szalontay also points out that DMG tumors are found in very sensitive areas of the brain, making traditional surgery or radiation risky because they could damage vital brain functions. This makes finding safe and effective treatments for these tumors even more challenging. So, what’s being done to tackle these obstacles and help kids fight these tumors?
A group of stick figures are holding hands around a globe.
April 4, 2024
World Health Day: Pediatric Cancer’s Global Divide Imagine this: Two children, born at the same moment, oceans apart. In a country brimming with medical resources, one child quickly gets top-notch treatment for cancer. Meanwhile, across the globe, the other child faces a drastically different reality, with limited access to basic care. This isn’t just a thought experiment — it’s the harsh truth of pediatric cancer treatment worldwide. Observed every year on April 7, World Health Day shines a light on the mission to make healthcare accessible for all. This day is particularly significant in the context of pediatric cancer, where vast disparities in treatment availability highlight the global challenge of ensuring every child has the opportunity for health and healing. The Stark Contrast in Survival Rates: A Look at Pediatric Cancer Statistics Every day, more than 1,000 children are diagnosed with cancer, and the chances of survival vary greatly depending on where they live.1 Pediatric cancer survival rates serve as a clear indicator of the disparities between high-income countries (HICs) and low- and middle-income countries (LMICs). In wealthier nations such as the United States and Western Europe, the 5-year survival rate for children with cancer is over 80%, thanks to advanced healthcare systems and access to the latest treatments.2 But, here’s a troubling childhood cancer statistic: in LMICs where 80% of children with cancer live, fewer than 20% survive.1 This gap is due to several factors, including late diagnoses or, tragically, no diagnosis at all. Many children succumb to the disease without access to pain medication, and the burdens of travel and the high costs force most families to abandon care. These challenges are compounded by limited access to necessary treatments,3 as well as a lack of specialized equipment and trained healthcare professionals needed for effective pediatric cancer treatment. Addressing this divide requires a concerted global effort to improve early detection, make treatments more affordable, and enhance healthcare infrastructures, giving every child a fair chance to beat cancer. Navigating the Access Maze Access to cancer care shouldn’t be a treasure hunt. Yet, for many in LMICs, it feels like that — a relentless search for something seemingly out of reach. Here’s the reality revealed in childhood cancer statistics worldwide: many areas lack enough doctors who specialize in children’s cancer4 and the prices of cancer drugs can be sky-high.2 Even getting to a hospital can be an ordeal, with some families traveling hundreds of miles. And the financial strain? Devastating. The cost of care can quickly add up to more than a year’s income, forcing households into deep financial distress. In many LMICs, the lack of comprehensive insurance coverage means families are often left to pay for pediatric cancer treatment entirely out-of-pocket.5 Families often face the impossible choice between their child’s health and their financial survival. Solving Kids’ Cancer: Bridging the Gap Solving Kids’ Cancer (SKC) isn’t standing by; we’re on the front lines, actively working to make a difference in the global pediatric cancer landscape. Beyond funding research, advocating for policy changes, and fostering global partnerships, SKC is committed to educating and empowering the community to take action. We understand that while we might not have a global foothold to address every aspect of the pediatric cancer divide directly, there’s power in collective action. Through our efforts, we aim to catalyze advancements in pediatric cancer treatments and care that could dramatically change outcomes for children worldwide. • Research: We direct funds into cutting-edge studies, searching for breakthrough treatments that promise a brighter future for all kids, regardless of where they live. • Advocacy: We advocate for children’s needs by steering research funding towards unmet challenges and collaborating with experts to prioritize all children, including expanding trials to international sites to maximize access.2 • Global Partnerships: We don’t do it alone. By teaming up with researchers, hospitals, and other organizations across the globe, we’ve helped fund clinical trials that have extended to over 250 institutions across 15 countries worldwide . Uniting for a Cause Solving Kids’ Cancer extends its mission beyond research by fostering community and collaboration. Our signature event, Lace Up for Kids , held annually during September Childhood Cancer Awareness Month, is a powerful testament to this mission, drawing communities together to stand in solidarity against childhood cancer. Additionally, supporters can create their own fundraiser and have a platform to engage their local communities, sparking crucial conversations and garnering support for the cause. These initiatives highlight an important fact: While the challenge of pediatric cancer is significant, each of us has a part to play. By working together and supporting each other, we can fund the research needed to possibly change the direction of pediatric cancer treatment and care worldwide. World Health Day: A Chance for Every Child The fight against pediatric cancer is a stark reminder of the work ahead of us.6 It’s a battle that Solving Kids’ Cancer is dedicated to, but we need more than just our efforts — we need a global movement. This World Health Day, let’s rally for every child’s right to fight cancer on an even playing field. Donate today to help fund more innovative research and one day find a cure for childhood cancer — because every child, no matter where they are born, deserves a chance — a chance to fight, a chance to survive, and a chance to thrive.
More Posts